Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.5B | 2.8B | 2.7B | 2.3B |
Cost of revenue | 3.2B | 2.5B | 2.4B | 2.0B |
Gross profit | 343.5M | 280.1M | 302.0M | 316.0M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 158.8M | 58.6M | 79.9M | 167.8M |
Operating income | 164.6M | 206.2M | 205.3M | 130.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 77.2M | 121.0M | 105.0M | 93.9M |
Other income expense | — | — | — | — |
Pretax income | 114.7M | 94.3M | 110.4M | 44.2M |
Tax provision | 28.9M | 23.6M | 28.9M | 13.3M |
Net income | 85.8M | 70.8M | 81.5M | 30.9M |
Basic EPS | — | 0.1 | 0.1 | 0.0 |
Diluted EPS | — | 0.1 | 0.1 | 0.0 |
Basic average shares | — | 1.0B | 1.0B | 1.0B |
Diluted average shares | — | 1.0B | 1.2B | 1.0B |
EBITDA | 194.7M | 218.3M | 218.4M | 141.0M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -81K | 35K | -16K |
Preferred stock dividends | 0 | 0 | 0 | 0 |